Approved Use & Safety Info
Approved Use
BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.
BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.
BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.
Important Safety Information About BEXSERO
Important Safety Information About BEXSERO
- Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
- Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
- The tip cap of the prefilled syringe may or may not be made with natural rubber latex. Natural rubber latex may cause allergic reactions
- Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare provider may ask you to sit or lie down for 15 minutes after receiving BEXSERO
- Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
- The tip cap of the prefilled syringe may or may not be made with natural rubber latex. Natural rubber latex may cause allergic reactions
- Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare provider may ask you to sit or lie down for 15 minutes after receiving BEXSERO
- BEXSERO may not protect all vaccine recipients
- Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
- Individuals with certain complement deficiencies and individuals receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis group B even after being vaccinated with BEXSERO
- The most common side effects are pain, redness or swelling at the injection site; fatigue; headache; nausea; and muscle pain
- Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breast-feeding
- Ask your healthcare provider about the risks and benefits of BEXSERO. Only a healthcare provider can decide if BEXSERO is right for you or your child
